Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

U.S. patent issued for meningococcal B vaccine

Feb. 11, 1997

CEAPRO receives patent coverage for potential vaccine adjuvants

Feb. 7, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Clinical trial data reported for meningitis vaccine

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

SmithKline Beecham Lyme disease vaccine update

Feb. 5, 1997

Tularik receives patent coverage for protein involved in immune response

Feb. 4, 1997

SKB acellular DTP vaccine approved in U.S.

Jan. 31, 1997

U.K. biotechnology company offers late-stage vaccine for licensing

Jan. 31, 1997

Astra investigates H. pylori vaccines

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...